Surmodics Inc
SRDX42.980USD
0.000
Close 12/24, 13:00（ET）Quotes delayed by 15 min
614.53MMarket Cap
LossP/E TTM
More Details of Surmodics Inc Company
Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the demanding requirements. Its segments include Medical Device and IVD. Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral and coronary. IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.
Surmodics Inc Info
Ticker SymbolSRDX
Company nameSurmodics Inc
IPO dateMar 04, 1998
CEOHance (Robert B)
Number of employees389
Security typeOrdinary Share
Fiscal year-endMar 04
Address9924 West 74th Street
CityEDEN PRAIRIE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code55344
Phone19525007000
Websitehttps://www.surmodics.com/
Ticker SymbolSRDX
IPO dateMar 04, 1998
CEOHance (Robert B)
Company Executives of Surmodics Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Charles W. Olson
Mr. Charles W. Olson
Vice President
Vice President
800.00
-98.47%
Mr. Robert B. (Chip) Hance
Mr. Robert B. (Chip) Hance
President, Chief Executive Officer, Assistant Secretary, Director
President, Chief Executive Officer, Assistant Secretary, Director
--
--
Mr. Scott D'Amour
Mr. Scott D'Amour
Chief Financial Officer, Vice President, Treasurer, Company Secretary, Director
Chief Financial Officer, Vice President, Treasurer, Company Secretary, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Charles W. Olson
Mr. Charles W. Olson
Vice President
Vice President
800.00
-98.47%
Mr. Robert B. (Chip) Hance
Mr. Robert B. (Chip) Hance
President, Chief Executive Officer, Assistant Secretary, Director
President, Chief Executive Officer, Assistant Secretary, Director
--
--
Mr. Scott D'Amour
Mr. Scott D'Amour
Chief Financial Officer, Vice President, Treasurer, Company Secretary, Director
Chief Financial Officer, Vice President, Treasurer, Company Secretary, Director
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
Domestic
104.64M
83.00%
Foreign
21.43M
17.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sat, Nov 22
Updated: Sat, Nov 22
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
7.09%
AllianceBernstein L.P.
6.21%
The Vanguard Group, Inc.
5.66%
Oddo BHF Asset Management S.A.S
4.27%
Hudson Bay Capital Management LP
3.75%
Other
73.02%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
7.09%
AllianceBernstein L.P.
6.21%
The Vanguard Group, Inc.
5.66%
Oddo BHF Asset Management S.A.S
4.27%
Hudson Bay Capital Management LP
3.75%
Other
73.02%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
30.42%
Investment Advisor
21.10%
Hedge Fund
20.69%
Research Firm
4.25%
Individual Investor
0.47%
Bank and Trust
0.46%
Pension Fund
0.41%
Sovereign Wealth Fund
0.22%
Insurance Company
0.03%
Other
21.94%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
312
12.95M
90.59%
-4.14M
2025Q2
321
12.64M
88.41%
-4.03M
2025Q1
343
12.58M
88.00%
-4.09M
2024Q4
362
12.66M
88.58%
-3.97M
2024Q3
348
12.66M
88.74%
-3.48M
2024Q2
329
13.91M
98.26%
-1.49M
2024Q1
308
13.31M
93.49%
-1.66M
2023Q4
311
13.68M
96.13%
-630.83K
2023Q3
314
12.98M
91.82%
-1.55M
2023Q2
312
12.97M
91.74%
-1.29M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
1.02M
7.13%
-27.06K
-2.58%
Jun 30, 2025
AllianceBernstein L.P.
850.47K
5.95%
+1.12K
+0.13%
Jun 30, 2025
The Vanguard Group, Inc.
810.18K
5.67%
+11.51K
+1.44%
Jun 30, 2025
Oddo BHF Asset Management S.A.S
268.10K
1.88%
+28.10K
+11.71%
Jun 30, 2025
Hudson Bay Capital Management LP
400.00K
2.8%
-64.97K
-13.97%
Jun 30, 2025
Qube Research & Technologies Ltd
393.98K
2.76%
+4.80K
+1.23%
Jun 30, 2025
Readystate Asset Management LP
433.61K
3.03%
+433.61K
--
Jun 30, 2025
Geode Capital Management, L.L.C.
336.24K
2.35%
+1.13K
+0.34%
Jun 30, 2025
State Street Investment Management (US)
320.88K
2.24%
-41.35K
-11.42%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
First Trust Merger Arbitrage ETF
9.7%
State Street SPDR S&P Health Care Equipment ETF
0.45%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.07%
iShares Micro-Cap ETF
0.07%
iShares U.S. Medical Devices ETF
0.05%
Franklin US Small Cap Multifactor Index ETF
0.04%
iShares Russell 2000 Growth ETF
0.02%
Proshares Ultra Russell 2000
0.01%
Schwab U.S. Small-Cap ETF
0.01%
Global X Russell 2000 ETF
0.01%
View more
First Trust Merger Arbitrage ETF
Proportion9.7%
State Street SPDR S&P Health Care Equipment ETF
Proportion0.45%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.07%
iShares Micro-Cap ETF
Proportion0.07%
iShares U.S. Medical Devices ETF
Proportion0.05%
Franklin US Small Cap Multifactor Index ETF
Proportion0.04%
iShares Russell 2000 Growth ETF
Proportion0.02%
Proshares Ultra Russell 2000
Proportion0.01%
Schwab U.S. Small-Cap ETF
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Surmodics Inc?
The top five shareholders of Surmodics Inc are:
BlackRock Institutional Trust Company, N.A. holds 1.02M shares, accounting for 7.13% of the total shares.
AllianceBernstein L.P. holds 850.47K shares, accounting for 5.95% of the total shares.
The Vanguard Group, Inc. holds 810.18K shares, accounting for 5.67% of the total shares.
Oddo BHF Asset Management S.A.S holds 268.10K shares, accounting for 1.88% of the total shares.
Hudson Bay Capital Management LP holds 400.00K shares, accounting for 2.80% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 1.02M shares, accounting for 7.13% of the total shares.
AllianceBernstein L.P. holds 850.47K shares, accounting for 5.95% of the total shares.
The Vanguard Group, Inc. holds 810.18K shares, accounting for 5.67% of the total shares.
Oddo BHF Asset Management S.A.S holds 268.10K shares, accounting for 1.88% of the total shares.
Hudson Bay Capital Management LP holds 400.00K shares, accounting for 2.80% of the total shares.
What are the top three shareholder types of Surmodics Inc?
The top three shareholder types of Surmodics Inc are:
BlackRock Institutional Trust Company, N.A.
AllianceBernstein L.P.
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
AllianceBernstein L.P.
The Vanguard Group, Inc.
How many institutions hold shares of Surmodics Inc (SRDX)?
As of 2025Q3, 312 institutions hold shares of Surmodics Inc, with a combined market value of approximately 12.95M, accounting for 90.59% of the total shares. Compared to 2025Q2, institutional shareholding has increased by 2.18%.
What is the biggest source of revenue for Surmodics Inc?
In FY2024, the -- business generated the highest revenue for Surmodics Inc, amounting to -- and accounting for --% of total revenue.
